It looks to us that Solvay will follow its chosen path by focusing on a creative set of figures. Based on the previous year’s pro-forma figures, Q2 sales were down 6% to €2,946m, whereas gross profit margin strongly rose from 27.0% to 29.0%. Underlying EBITDA (no chance for adjustments) strongly grew by +35% to €453m and net income attributable to shareholders jumped +48% to €185m. Operating CF was burdened by higher NWC outflow and higher provisions coming in at €35
29 Jul 2016
Stuck on its struck path
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Stuck on its struck path
Solvay SA (SOLB:WBO) | 0 0 0.5% | Mkt Cap: 11,953m
- Published:
29 Jul 2016 -
Author:
Martin Schnee -
Pages:
3
It looks to us that Solvay will follow its chosen path by focusing on a creative set of figures. Based on the previous year’s pro-forma figures, Q2 sales were down 6% to €2,946m, whereas gross profit margin strongly rose from 27.0% to 29.0%. Underlying EBITDA (no chance for adjustments) strongly grew by +35% to €453m and net income attributable to shareholders jumped +48% to €185m. Operating CF was burdened by higher NWC outflow and higher provisions coming in at €35